Reported 1 day ago
AbbVie is highlighted as one of the top pharmaceutical stocks to consider for investment due to its impressive portfolio, including 12 blockbuster drugs generating nearly $47 billion in sales last year, and a consistent dividend yield of about 3%. The company's solid revenue growth and commitment to shareholder returns position it as a strong candidate, despite not being listed among the top 10 recommendations by The Motley Fool's analyst team.
Source: YAHOO